Hanley SJB - Search Results

1

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion.

Dong P, Xiong Y, Yue J, Hanley SJB, Watari H. Dong P, et al. Among authors: hanley sjb. Front Oncol. 2018 Sep 19;8:386. doi: 10.3389/fonc.2018.00386. eCollection 2018. Front Oncol. 2018. PMID: 30283733 Free PMC article. Review.

2

Risk factors for persistent low bladder compliance after radical hysterectomy.

Oda Y, Todo Y, Hanley S, Hosaka M, Takeda M, Watari H, Kaneuchi M, Kudo M, Sakuragi N. Oda Y, et al. Int J Gynecol Cancer. 2011 Jan;21(1):167-72. doi: 10.1097/IGC.0b013e318204c3df. Int J Gynecol Cancer. 2011. PMID: 21330841

3

Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.

Hosaka M, Fujita H, Hanley SJ, Sasaki T, Shirakawa Y, Abiko M, Kudo M, Kaneuchi M, Watari H, Kikuchi K, Sakuragi N. Hosaka M, et al. Int J Cancer. 2013 Jan 15;132(2):327-34. doi: 10.1002/ijc.27680. Epub 2012 Jul 3. Int J Cancer. 2013. PMID: 22729477 Free article.

4

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.

Konno Y, Dong P, Xiong Y, Suzuki F, Lu J, Cai M, Watari H, Mitamura T, Hosaka M, Hanley SJ, Kudo M, Sakuragi N. Konno Y, et al. Oncotarget. 2014 Aug 15;5(15):6049-62. doi: 10.18632/oncotarget.2157. Oncotarget. 2014. PMID: 25153722 Free PMC article.

5

Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors.

Dong P, Ihira K, Hamada J, Watari H, Yamada T, Hosaka M, Hanley SJ, Kudo M, Sakuragi N. Dong P, et al. Oncotarget. 2015 Aug 21;6(24):19968-75. doi: 10.18632/oncotarget.4847. Oncotarget. 2015. PMID: 26343523 Free PMC article. Review.

6

HPV self-sampling in Japanese women: A feasibility study in a population with limited experience of tampon use.

Hanley SJ, Fujita H, Yokoyama S, Kunisawa S, Tamakoshi A, Dong P, Kobayashi N, Watari H, Kudo M, Sakuragi N. Hanley SJ, et al. J Med Screen. 2016 Sep;23(3):164-70. doi: 10.1177/0969141315625702. Epub 2016 Feb 25. J Med Screen. 2016. PMID: 26919866

7

Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.

Dong P, Ihira K, Xiong Y, Watari H, Hanley SJ, Yamada T, Hosaka M, Kudo M, Yue J, Sakuragi N. Dong P, et al. Oncotarget. 2016 Apr 12;7(15):20260-70. doi: 10.18632/oncotarget.7754. Oncotarget. 2016. PMID: 26934121 Free PMC article.

8

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.

Dong P, Xiong Y, Watari H, Hanley SJ, Konno Y, Ihira K, Yamada T, Kudo M, Yue J, Sakuragi N. Dong P, et al. J Exp Clin Cancer Res. 2016 Sep 5;35(1):132. doi: 10.1186/s13046-016-0415-y. J Exp Clin Cancer Res. 2016. PMID: 27596137 Free PMC article.

9

Challenges in breast and cervical cancer control in Japan.

Hanley SJ, Fujita H, Tamakoshi A, Dong P, Sakuragi N. Hanley SJ, et al. Lancet Oncol. 2016 Sep;17(9):e372. doi: 10.1016/S1470-2045(16)30411-9. Epub 2016 Aug 30. Lancet Oncol. 2016. PMID: 27599140 No abstract available.

10

Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.

Dong P, Xiong Y, Watari H, Hanley SJ, Konno Y, Ihira K, Suzuki F, Yamada T, Kudo M, Yue J, Sakuragi N. Dong P, et al. Sci Rep. 2016 Oct 21;6:35480. doi: 10.1038/srep35480. Sci Rep. 2016. PMID: 27765948 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page